[Answered] Oxytocin dampens activity in which brain area? a. thalamus c. cortex b. hypothalamus d. ...

This topic contains a solution. Click here to go to the answer

Author Question: Oxytocin dampens activity in which brain area? a. thalamus c. cortex b. hypothalamus d. ... (Read 45 times)

khang

Hero Member
Posts: 569

on: Jun 18, 2018

Oxytocin dampens activity in which brain area?

a. thalamus c. cortex
b. hypothalamus d. amygdala

Question 2

Dopamine (DA) and norepinephrine (NE) are neurotransmitters that are involved in ____.

a. intelligence c. motivation
b. depression d. anger

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

cegalasso

Sr. Member
Posts: 295

Reply #1 on: Jun 18, 2018

Answer to Question 1

ANS: D

Answer to Question 2

ANS: C

khang

Member
Posts: 569

Reply 2 on: Jun 18, 2018

Thanks for the timely response, appreciate it

Jossy

Member
Posts: 336

Reply 3 on: Yesterday

Great answer, keep it coming

« previous next »

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

The first war in which wide-scale use of anesthetics occurred was the Civil War, and 80% of all wounds were in the extremities.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.